Evolent Health, Inc. (EVH) Earnings History
Annual and quarterly earnings data from 2012 to 2025
Loading earnings history...
EVH EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
EVH Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 15.1% | -0.2% | -28.5% |
| 2024 | 14.4% | -1.6% | -2.4% |
| 2023 | 23.4% | -3.6% | -5.8% |
| 2022 | 23.4% | 0.3% | -1.4% |
| 2021 | 27.6% | -4.7% | -4.1% |
Download Data
Export EVH earnings history in CSV or JSON format
Free sign-in required to download data
Evolent Health, Inc. (EVH) Earnings Overview
As of May 8, 2026, Evolent Health, Inc. (EVH) reported trailing twelve-month net income of -$497M, reflecting -525.9% year-over-year growth. The company earned $-4.44 per diluted share over the past four quarters, with a net profit margin of -28.5%.
Looking at the long-term picture, EVH's historical earnings data spans multiple years. The company achieved its highest annual net income of $332M in fiscal 2015.
Evolent Health, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including PINC (-$24M net income, 2.0% margin), ALHC ($20M net income, -0.0% margin), HQY ($215M net income, 16.4% margin), EVH has room to improve margins relative to the peer group. Compare EVH vs PINC →
EVH Earnings vs Peers
Earnings metrics vs comparable public companies
EVH Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$535M | -767.4% | -$4M | $-5.07 | -28.5% | -0.2% |
| 2024 | -$62M | +45.5% | -$40M | $-0.81 | -2.4% | -1.6% |
| 2023 | -$113M | -489.9% | -$71M | $-1.28 | -5.8% | -3.6% |
| 2022 | -$19M | +49.0% | $4M | $-0.20 | -1.4% | 0.3% |
| 2021 | -$38M | +88.8% | -$42M | $-0.36 | -4.1% | -4.7% |
| 2020 | -$334M | -10.7% | -$263M | $-3.94 | -36.1% | -28.4% |
| 2019 | -$302M | -473.5% | -$309M | $-3.71 | -43.9% | -45.0% |
| 2018 | -$53M | +13.2% | -$47M | $-0.68 | -8.4% | -7.6% |
| 2017 | -$61M | +62.0% | -$73M | $-0.94 | -13.9% | -16.7% |
| 2016 | -$160M | -148.0% | -$237M | $-3.55 | -62.8% | -93.4% |
See EVH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EVH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare EVH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonEVH — Frequently Asked Questions
Quick answers to the most common questions about buying EVH stock.
Is EVH growing earnings?
EVH EPS fell to $-4.44, with earnings declining -525.9%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-497M.
What are EVH's profit margins?
Evolent Health, Inc. net margin is -28.5%, with operating margin at -0.2%. Below-average margins reflect competitive or cost pressures.
How consistent are EVH's earnings?
EVH earnings data spans 2012-2025. The declining earnings trend is -525.9% YoY. Historical data enables comparison across business cycles.